Suppr超能文献

类风湿性关节炎患者角膜参数的评估。

Assessment of corneal parameters in patients with rheumatoid arthritis.

作者信息

Özkaya Dilek, Doğru Atalay, Baykal Tuba

机构信息

Department of Ophthalmology, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.

Department of Rheumatology, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.

出版信息

Indian J Ophthalmol. 2024 Feb 1;72(2):206-210. doi: 10.4103/ijo.IJO_2024_22. Epub 2024 Jan 25.

Abstract

PURPOSE

To assess the corneal parameters in rheumatoid arthritis (RA) patients.

METHODS

We enrolled 64 patients with RA (32 receiving biologic and 32 receiving conventional drugs) and 32 healthy subjects. Keratometric values (anterior flat [K1], steep [K2], and mean keratometry [Km]), corneal thickness from the pupil center (CCT), apex (ACT), and the thinnest point (TCT), and corneal volume (CV) were measured and compared between the groups.

RESULTS

K1, K2, and Km values were significantly higher in the RA group (P = 0.013, P = 0.048, P = 0.027, respectively). The means of CCT, ACT, TCT, and CV were significantly lower in RA patients (P < 0.001, P < 0.001, P < 0.001, P = 0.011, respectively). When we divided RA patients into two groups according to the treatment and compared them to controls, the differences in K1, CCT, ACT, TCT and CV were significant (P = 0.030, P = 0.005, P = 0.001, P = 0.001, P = 0.034, respectively). K1 and CV values of RA-biologic group were similar to the control group (P = 0.205 and P = 0.127, respectively).

CONCLUSION

Biologic agents contribute to the improvement of K1 and CV values in patients with RA.

摘要

目的

评估类风湿关节炎(RA)患者的角膜参数。

方法

我们纳入了64例RA患者(32例接受生物制剂治疗,32例接受传统药物治疗)以及32名健康受试者。测量并比较了两组之间的角膜曲率值(前表面平坦曲率[K1]、陡峭曲率[K2]和平均角膜曲率[Km])、瞳孔中心角膜厚度(CCT)、角膜顶点厚度(ACT)和最薄点角膜厚度(TCT)以及角膜体积(CV)。

结果

RA组的K1、K2和Km值显著更高(分别为P = 0.013、P = 0.048、P = 0.027)。RA患者的CCT、ACT、TCT和CV平均值显著更低(分别为P < 0.001、P < 0.001、P < 0.001、P = 0.011)。当我们根据治疗方法将RA患者分为两组并与对照组进行比较时,K1、CCT、ACT、TCT和CV的差异具有统计学意义(分别为P = 0.030、P = 0.005、P = 0.001、P = 0.001、P = 0.034)。RA-生物制剂组的K1和CV值与对照组相似(分别为P = 0.205和P = 0.127)。

结论

生物制剂有助于改善RA患者的K1和CV值。

相似文献

1
Assessment of corneal parameters in patients with rheumatoid arthritis.类风湿性关节炎患者角膜参数的评估。
Indian J Ophthalmol. 2024 Feb 1;72(2):206-210. doi: 10.4103/ijo.IJO_2024_22. Epub 2024 Jan 25.

本文引用的文献

2
When rheumatoid arthritis is mentioned, should only dryness come to mind?当提到类风湿关节炎时,难道只能想到干燥吗?
Clin Rheumatol. 2020 Nov;39(11):3317-3321. doi: 10.1007/s10067-020-05124-1. Epub 2020 May 9.
3
Rheumatoid Arthritis: A Brief Overview of the Treatment.类风湿关节炎:治疗简述。
Med Princ Pract. 2018;27(6):501-507. doi: 10.1159/000493390. Epub 2018 Sep 2.
5
Assessment of Corneal Densitometry in Rheumatoid Arthritis Patients.类风湿关节炎患者角膜测厚术的评估
Turk J Ophthalmol. 2017 Jun;47(3):125-129. doi: 10.4274/tjo.89577. Epub 2017 Jun 1.
9
Corneal Biomechanical Properties in Rheumatoid Arthritis.类风湿关节炎中的角膜生物力学特性
Eye Contact Lens. 2015 Nov;41(6):382-5. doi: 10.1097/ICL.0000000000000142.
10
Ocular inflammatory diseases associated with rheumatoid arthritis.与类风湿关节炎相关的眼部炎症性疾病。
Nat Rev Rheumatol. 2014 Feb;10(2):108-16. doi: 10.1038/nrrheum.2013.185. Epub 2013 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验